<DOC>
	<DOC>NCT01792713</DOC>
	<brief_summary>Investigation aimed to explore the efficacy of a topical Sertaconazole cream 2% in patients with skin alterations associated with atopic dermatitis</brief_summary>
	<brief_title>Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Sertaconazole</mesh_term>
	<criteria>Informed consent Atopic Dermatitis Patients with SCORing Atopic Dermatitis (SCORAD) â‰¤ 40 Atopic lesion localisation: arms; additional legs, neck SCORAD &gt; 40 Unstable, uncontrolled medical status (e.g. active systemic or topical infection) Active immunosuppression or cancer Narcotics or Alcohol abuse Participation in another clinical trial until one month prior inclusion Known allergies against an ingredient of the investigational medicinal product Different periods of grace for certain pretreatments, e.g. topical corticosteroids, immune modulating drugs Pregnancy or lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Skin alterations</keyword>
	<keyword>Atopic Dermatitis</keyword>
</DOC>